Chung C S, Myrianthopoulos N C
Birth Defects Orig Artic Ser. 1975;11(10):23-38.
The effect of maternal diabetes on the risk of congenital malformations was investigated in 23,695 pregnancies of white mothers, inclucing 339 patients of the Joslin Clinic, and in 24,742 pregnancies of Negro mothers, drawn from the prospective Collaborative Perinatal Project. Of these, 372 mothers had gestational diabetes and 567 had overt diabetes (before and during pregnancy). Pregnancy outcomes studied included stillbirths and live births. Among core women (excluding the Joslin Clinic cases), the frequencies of diabetic pregnancies were 1.31% and 1.18% for white and Negro mothers, respectively; in both groups, approximately two thirds of these pregnancies had gestational diabetes. There was no increase in malformation risk in the pregnancies of mothers with gestational diabetes over that of nondiabetic mothers in either racial group. However, the risk of malformation for white mothers with overt diabetes was double that of nondiabetic mothers for both major and minor categories of malformations. The incidences of major and minor types of malformations in the pregnancies of white mothers with overt diabetes were 17.94% and 10.94%, respectively, compared to the corresponding incidences of 8.34% and 6.25% for the white nondiabetic group. In Negro mothers with overt diabetes, a smaller increase of risk was seen only in major malformations; the incidences were 13.64% and 8.45% for the diabetic and nondiabetic groups, respectively. The increased risks for malformations were distributed generally throughout the organ systems. Multiple malformations occurred more frequently in the overt diabetic than in the nondiabetic group, suggesting that maternal diabetes must act adversely an an early stage of fetal development. Two cases with the caudal regression syndrome were observed in children of diabetic mothers, whereas none was found among births from nondiabetic mothers. Insulin (or analog) therapy of diabetes neither decreased nor increased the risk of malformation in the fetus. However, duration of diabetes had a significant effect on the malformation risk: the longer the mother had the disease, the higher was the incidence of malformations in the fetus. Paternal diabetes did not contribute to increase in risk. These observations suggest that maternal diabetes per se, through its adverse effects on maternal metabolism, is the responsible factor for the increase of malformations in the offspring.
在23695例白人母亲的妊娠中(包括339例乔斯林诊所的患者)以及从围产期协作项目前瞻性研究中选取的24742例黑人母亲的妊娠中,研究了母亲患糖尿病对胎儿先天性畸形风险的影响。其中,372名母亲患有妊娠期糖尿病,567名母亲患有显性糖尿病(孕前及孕期)。所研究的妊娠结局包括死产和活产。在核心女性(不包括乔斯林诊所的病例)中,白人母亲和黑人母亲糖尿病妊娠的发生率分别为1.31%和1.18%;在两组中,这些妊娠中约三分之二为妊娠期糖尿病。在两个种族群体中,患有妊娠期糖尿病母亲的妊娠中畸形风险均未高于非糖尿病母亲。然而,患有显性糖尿病的白人母亲所生胎儿的畸形风险在主要和次要畸形类别中均是非糖尿病母亲的两倍。患有显性糖尿病的白人母亲所生胎儿中主要和次要畸形类型的发生率分别为17.94%和10.94%,相比之下,白人非糖尿病组相应的发生率为8.34%和6.25%。在患有显性糖尿病的黑人母亲中,仅在主要畸形中观察到风险有较小幅度的增加;糖尿病组和非糖尿病组的发生率分别为13.64%和8.45%。畸形风险增加普遍分布于各个器官系统。显性糖尿病组中多发畸形的发生频率高于非糖尿病组,这表明母亲患糖尿病一定在胎儿发育的早期就产生了不利影响。在糖尿病母亲的孩子中观察到2例尾椎退化综合征病例,而在非糖尿病母亲的分娩中未发现此类病例。糖尿病的胰岛素(或类似物)治疗既未降低也未增加胎儿的畸形风险。然而,糖尿病病程对畸形风险有显著影响:母亲患糖尿病的时间越长,胎儿畸形的发生率越高。父亲患糖尿病并未导致风险增加。这些观察结果表明,母亲患糖尿病本身通过对母体代谢产生不利影响,是后代畸形增加的责任因素。